Financial Architects, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Financial Architects, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$544.75 - $658.21 $16,342 - $19,746	-30 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $11,839 - $15,454	24 Added 400.0%	30 $19,000
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $2,017 - $2,966	6 New	6 $3,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $7,789 - $10,785	-26 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $9,674 - $11,428	26 New	26 $11,000
Q1 2019 May 03, 2019	SELL	$372.08 - $439.57 $66,974 - $79,122	-180 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$351.14 - $408.51 $35,114 - $40,851	-100 Reduced 35.71%	180 $73,000
Q1 2018 Apr 23, 2018	BUY	$315.82 - $393.78 $41,688 - $51,978	132 Added 89.19%	280 $96,000
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $35,863 - $46,995	100 Added 208.33%	148 $56,000
Q3 2017 Nov 01, 2017	BUY	$431.38 - $504.0 $20,706 - $24,192	48	48 $21,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.